IL17A and Alzheimer disease: In contrast to low NOS2 expression in AD lesions, Köhler et al. identified significantly increased NOS2 mRNA expression in psoriatic epidermis and proved that NOS2-derived low levels of NO mediated downstream psoriatic effects of IL-17 [48].